Oxidative stress activates MMP-2 in cultured human coronary smooth muscle cells

Fundamental and Clinical Pharmacology

Volumn 19, Issue 6, 2005, Pages 661-667

  Valentin, François ^a,b,c   Bueb, Jean Luc ^a,d   Kieffer, Pascal ^b   Tschirhart, Eric ^a,d   Atkinson, Jeffrey ^b  

^a LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^b UNIVERSITÉ DE LORRAINE   (France)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF LUXEMBOURG   (Luxembourg)

Author keywords

Human coronary artery smooth muscle cells; MMP 2 activation; MT1 MMP expression; Oxidative radicals; Oxidized LDL

Indexed keywords

ENZYME ANTIBODY; GELATINASE A; INTERSTITIAL COLLAGENASE; LOW DENSITY LIPOPROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; XANTHINE; XANTHINE OXIDASE;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; CORONARY ARTERY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY; BIOSYNTHESIS; ENZYME INDUCTION; ENZYMOLOGY; HEART MUSCLE; METABOLISM; POLYACRYLAMIDE GEL ELECTROPHORESIS;

CELLS, CULTURED; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MATRIX METALLOPROTEINASE 2; MYOCARDIUM; OXIDATIVE STRESS;

EID: 33645211800     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2005.00371.x     Document Type: Article

References (27)

1. Laitinen L., Laitinen A, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am. Rev. Respir. Dis. (1993) 147 697-704.
2. Beckman J., Beckman T., Chen J., Marshall P., Freeman B. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U.S.A. (1990) 87 1620-1624.
3. Warnholtz A., Nickenig G., Schulz E. et al. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation (1999) 99 2027-2033.
4. Darley-Usmar V., Hogg N., O'Leary V., Wilson M., Moncada S. The simultaneous generation of Superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. Free Radic. Res. Commun. (1992) 17 9-20.
5. Wick G., Schett G., Amberger A., Kleindienst R., Xu Q. Is atherosclerosis an immunologically mediated disease? Immunol. Today (1995) 16 27-33.
6. Huang Y., Mironova M., Lopes-Virella M. Oxidized LDL stimulates matrix metalloprotemase-1 expression in human vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. (1999) 19 2640-2647.
7. Rajagopalan S., Meng X., Ramasamy S., Harrison D., Galis Z. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J. Clin. Invest. (1996) 98 2572-2579.
8. Falk E., Shah P., Fuster V. Coronary plaque disruption. Circulation (1995) 92 657-671.
9. Olson M., Gervasi D., Mobashery S., Fridman R. Kinetic analysis of the binding of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2. J. Biol. Chem. (1997) 272 29975-29983.
10. Jing Q., Xin S., Cheng Z. et al. Activation of p38 mitogen-activated protein kinase by oxidized LDL in vascular smooth muscle cells: mediation via pertussis toxin-sensitive G proteins and association with oxidized LDL-induced cytotoxicity. Circ. Res. (1999) 84 831-839.
11. Schuh J., Fairclough G. Jr, Haschemeyer R. Oxygen-mediated heterogeneity of apo-low-density lipoprotein. Proc. Natl. Acad. Sci. U.S.A. (1978) 75 3173-3177.
12. Rajavashisth T., Xu X.P., Jovinge S. et al. Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators. Circulation (1999) 99 3103-3109.
13. Kwan C., Triggle C., Grover A., Lee R., Daniel E. An analytical approach to the preparation and characterization of subcellular membranes from canine mesenteric arteries. Prep. Biochem. (1983) 13 275-314.
14. Lowry O, Rosebrough N., Farr A., Randall R. Protein measurement with the folin phenol reagent. J. Biol. Chem. (1951) 193 265-275.
15. Laemmli U. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 227 680-685.
16. Strongin A., Collier I., Bannikov G., Marmer B., Grant G., Goldberg G. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. (1995) 270 5331-5338.
17. Schraufstatter I., Browne K., Harris A. et al. Mechanisms of hypochlorite injury of target cells. J. Clin. Invest. (1990) 85 554-562.
18. Galis Z., Sukhova G., Lark M., Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. (1994) 94 2493-2503.
19. Dollery C., McEwan J., Henney A. Matrix metalloproteinases and cardiovascular disease. Circ. Res. (1995) 77 863-868.
20. Butler G., Butler M., Atkinson S. et al. The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study. J. Biol. Chem. (1998) 273 871-880.
21. Rajavashisth T., Liao J., Galis Z. et al. Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase. J. Biol. Chem. (1999) 274 11924-11929.
22. Shofuda K., Yasumitsu H., Nishihashi A., Miki K., Miyazaki K. Expression of three membrane-type matrix metalloproteinases (MT-MMPs) in rat vascular smooth muscle cells and characterization of MTS-MMPs with and without transmembrane domain. J. Biol. Chem. (1997) 272 9749-9754.
23. Ushio-Fukai M., Alexander R., Akers M., Griendling K. p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J. Biol. Chem. (1998) 273 15022-15029.
24. Fliss H., Menard M. Oxidant-induced mobilization of zinc from metallothionein. Arch. Biochem. Biophys. (1992) 293 195-199.
25. Goldberg G., Manner B., Grant G., Eisen A., Wilhelm S., He C. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc. Natl. Acad. Sci. U.S.A. (1989) 86 8207-8211.
26. Siwik D.A., Pagano P.J., Colucci W.S. Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. Am. J. Physiol. Cell. Physiol. (2001) 280 C53-C60.
27. Liu W., Rosenberg G.A., Shi H. et al. Xanthine oxidase activates pro-matrix metalloproteinase-2 in cultured rat vascular smooth muscle cells through non-free radical mechanisms. Arch. Biochem. Biophys. (2004) 426 11-17.